QIAGEN (QGEN)
(Delayed Data from NYSE)
$42.58 USD
-0.40 (-0.93%)
Updated May 6, 2024 04:00 PM ET
After-Market: $42.57 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
QIAGEN N.V. [QGEN]
Reports for Purchase
Showing records 161 - 180 ( 234 total )
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
3Q15 Pre-Call Summary - Results A Tad Soft - Key MoDx Franchise Wobbly In Part Due to Asia - Opex - FCF Improving - Maintain N - PT to $20
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 27
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
1Q15 Preview - Lowering Forecasts Slightly - Expecting Sales to Edge Higher With In-line EPS - Maintain N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Final 4Q14 Recap - Lower Estimates Offset By An Interesting Two-Quarter System Sales Growth Trend - FCF Ok - Reaffirm NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z